GPCR Desensitization
Drug Discovery: Overview
GPCRs Regulate Adenylyl Cylase Activity
Patch Clamp
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Sep 20, 2025

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery
Published on: June 28, 2019
Toon Laeremans1, Zara A Sands1, Pieter Claes1
1Confo Therapeutics NV, Zwijnaarde, Belgium.
Camelid-derived single variable domains (ConfoBodies) stabilize G protein-coupled receptors (GPCRs) for drug discovery. These tools enhance screening and structure-based design, accelerating the development of novel GPCR-targeted therapeutics.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: